CHAPTER 1 INTRODUCTION

1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. KEY PLAYERS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK AND REIMBURSEMENT SCENARIO
3.5. TOP PLAYER POSITIONING, 2016
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Rise in incidence rate of breast cancer
3.6.1.2. Advent of novel and minimal invasive biopsy procedures
3.6.1.3. Increase in number of breast cancer screening programs
3.6.1.4. Technological advancements in breast imaging equipment

3.6.2. Restraints

3.6.2.1. Uncertain regulatory issues
3.6.2.2. Infectious risk associated with breast biopsy procedures
3.6.2.3. High cost and unclear reimbursement policies

3.6.3. Opportunities

3.6.3.1. Untapped emerging economies
3.6.3.2. Increasing awareness regarding breast cancer

CHAPTER 4 GLOBAL BREAST BIOPSY MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Key market trends
4.1.2. Growth factors and opportunities
4.1.3. Market size and forecast

4.2. VACUUM ASSISTED BIOPSY (VAB)

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. CORE NEEDLE BIOPSY (CNB)

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. FINE NEEDLE ASPIRATION BIOPSY (FNAB)

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

CHAPTER 5 GLOBAL BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. MRI-GUIDED BREAST BIOPSY

5.2.1. Market size and forecast

5.3. ULTRASOUND GUIDED BREAST BIOPSY

5.3.1. Market size and forecast

5.4. MAMMOGRAPHY GUIDED STEREOTACTIC BIOPSY

5.4.1. Market size and forecast

5.5. CT-GUIDED BIOPSY

5.5.1. Market size and forecast

5.6. OTHER IMAGE GUIDED BREAST BIOPSY

5.6.1. Market size and forecast

CHAPTER 6 GLOBAL BREAST BIOPSY MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. DIAGNOSTIC CENTER

6.2.1. Market size and forecast

6.3. HOSPITAL

6.3.1. Market size and forecast

CHAPTER 7 BREAST BIOPSY MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Growth factors and opportunities
7.2.3. Market size and forecast by Country
7.2.4. Market size and forecast by Product
7.2.5. Market size and forecast by Image Guided Technology
7.2.6. Market size and forecast by End User

7.2.6.1. U.S. market size and forecast
7.2.6.2. Canada market size and forecast
7.2.6.3. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Growth factors and opportunities
7.3.3. Market size and forecast by Country
7.3.4. Market size and forecast by Product
7.3.5. Market size and forecast by Image Guided Technology
7.3.6. Market size and forecast by End User

7.3.6.1. UK market size and forecast
7.3.6.2. France market size and forecast
7.3.6.3. Germany market size and forecast
7.3.6.4. Italy market size and forecast
7.3.6.5. Spain market size and forecast
7.3.6.6. Russia market size and forecast
7.3.6.7. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Growth factors and opportunities
7.4.3. Market size and forecast by Country
7.4.4. Market size and forecast by Product
7.4.5. Market size and forecast by Image Guided Technology
7.4.6. Market size and forecast by End User

7.4.6.1. Japan market size and forecast
7.4.6.2. China market size and forecast
7.4.6.3. India market size and forecast
7.4.6.4. Australia market size and forecast
7.4.6.5. Singapore market size and forecast
7.4.6.6. Philippines market size and forecast
7.4.6.7. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Growth factors and opportunities
7.5.3. Market size and forecast by Country
7.5.4. Market size and forecast by Product
7.5.5. Market size and forecast by Image Guided Technology
7.5.6. Market size and forecast by End User

7.5.6.1. Brazil market size and forecast
7.5.6.2. Turkey market size and forecast
7.5.6.3. Israel market size and forecast
7.5.6.4. Saudi Arabia market size and forecast
7.5.6.5. South Africa market size and forecast
7.5.6.6. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. HOLOGIC INC.

8.1.1. Company overview
8.1.2. Operating business segments
8.1.3. Business performance
8.1.4. Key strategic moves and developments

8.2. LEICA BIOSYSTEMS NUSSLOCH GMBH (DEVICOR MEDICAL PRODUCTS, INC.)

8.2.1. Company overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategic moves and developments

8.3. C. R. BARD, INC.

8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Business performance
8.3.4. Key strategic moves and developments

8.4. BECTON DICKINSON AND COMPANY

8.4.1. Company overview
8.4.2. Operating business segments
8.4.3. Business performance
8.4.4. Key strategic moves and developments

8.5. ARGON MEDICAL DEVICES

8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Business performance
8.5.4. Key strategic moves and developments

8.6. COOK MEDICAL INCORPORATED

8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Business performance
8.6.4. Key strategic moves and developments

8.7. ENCAPSULE MEDICAL DEVICES LLC.

8.7.1. Company overview
8.7.2. Operating business segments
8.7.3. Business performance
8.7.4. Key strategic moves and developments

8.8. ETHICON ENDO SURGERY (JOHNSON & JOHNSON)

8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Business performance
8.8.4. Key strategic moves and developments

8.9. INTACT MEDICAL CORPORATION

8.9.1. Company overview
8.9.2. Operating business segments
8.9.3. Business performance
8.9.4. Key strategic moves and developments

8.10. GALINI SRL

8.10.1. Company overview
8.10.2. Operating business segments
8.10.3. Business performance
8.10.4. Key strategic moves and developments